Our study examines how RNA in extracellular vesicles (EVs) can provide insights into metabolic phenotypes related to obesity.

Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.

Seoul, Seoul / Syndication Cloud / July 13, 2025 / Lydian Cosmetic Surgery Clinic Key Takeaways: Orthopedic non-invasive stem cell therapy regenerates damaged tissue rather than just improving ...

Emeli Chatterjee, Ph.D., of the Cardiovascular Research Center at Massachusetts General Hospital, is the lead author and ...

Q: How would you summarize your study for a lay audience?Our study examines how RNA in extracellular vesicles (EVs) can provide insights into ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

Adipose tissue (AT) plays a central role in both metabolic health and pathophysiology. Its expansion in obesity results in increased mortality and morbidity, with contributions to cardiovascular ...